StockDocs
Main Newswire Learn
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BMGL

Basel Medical Group Ltd

BMGL Nasdaq Services-Offices & Clinics of Doctors of Medicine EDGAR ↗
$3.10
-0.37 -10.66%

Key statistics

from XBRL data in SEC filings
Market cap ⓘ
$58.2M
Revenue (TTM) ⓘ
—
Net income (TTM) ⓘ
—
EPS (TTM) ⓘ
—
P/E ratio ⓘ
—
Dividend yield ⓘ
—
Free cash flow ⓘ
—
Cash ⓘ
—
Total assets ⓘ
—
Gross margin ⓘ
—
52-week range ⓘ
$3.04 – $22.20

AI briefing

from the latest 10-K, 10-Q and 8-K events

Basel Medical Group Ltd is a Singapore-based healthcare provider operating a network of medical clinics and related entities, listed with the SEC (CIK 0002004489).

What they do

Basel Medical Group Ltd, through its subsidiaries, operates medical clinics and services in Singapore, focusing on orthopedic and sports medicine through entities such as Singapore Sports Orthopaedic Clinic Pte Ltd and Singapore Knee Sports and Orthopaedic Clinic Pte Ltd. The company also operates other medical clinics, including Bethesda Medical Pte Ltd and Oasis Medical Clinic Pte Ltd, and provides medical services and supplies through Pharma Avenue Pte Ltd and Basel Medflow Pte Ltd. Revenue is generated from medical services provided at these clinics.

Revenue drivers

  • Medical Services — Revenue is derived from medical services provided through the company's clinics and subsidiaries, primarily in Singapore. This is the sole revenue source reported in the filing.

Recent performance

The filing does not provide specific revenue or earnings figures for the fiscal year ended June 30, 2025, or the prior year. The excerpts reference financial statement line items such as property, plant and equipment, but no quantitative results are included. Therefore, recent performance cannot be summarized from the provided information.

Strategy

The filing excerpts do not disclose management's strategic priorities or future plans. No statements about investments, expansions, or operational initiatives are included.

Risks

  • Reliance on Singapore Operations — The company's operations are concentrated in Singapore, exposing it to local economic, regulatory, and competitive conditions.
  • Healthcare Regulation — As a healthcare provider, the company is subject to extensive regulations that could change and impact its operations.
  • Competition — The medical clinic industry in Singapore may be highly competitive, potentially affecting patient volumes and pricing.
  • COVID-19 or Pandemic Risks — Future pandemics or health crises could disrupt clinic operations and patient demand, as seen globally in recent years.

Outlook

The filing excerpts do not include any forward-looking statements or guidance from management regarding future periods.